Target intelligence / Profile preview

Vaginal polymicrobial biofilm

Molecular classification
Biofilm, Microbial community, Extracellular polymeric substance (EPS) matrix
01

Overview

Vaginal polymicrobial biofilms are dense, structured microbial communities primarily composed of Gardnerella vaginalis and various anaerobic species, such as Atopobium vaginae and Prevotella, which adhere to the vaginal epithelium (Swidsinski et al., 2005). These biofilms are encased in a protective extracellular polymeric substance (EPS) matrix that facilitates bacterial persistence by providing a physical barrier against host immune defenses and antimicrobial agents (Machado et al., 2015). As the hallmark of bacterial vaginosis (BV), these biofilms are responsible for the characteristic clue cells observed in clinical diagnostics and are strongly linked to the high rates of treatment failure and recurrence (Muzny et al., 2019). The biofilm structure allows for synergistic interactions between different bacterial species, enhancing their collective resistance to standard antibiotic therapies like metronidazole (Cerca et al., 2022). Effective management of BV increasingly requires therapeutic strategies that specifically target the biofilm architecture, such as the use of boric acid or specialized antiseptics, to disrupt the EPS and allow for the eradication of sequestered pathogens. Understanding the dynamics of these biofilms is crucial for developing treatments that can successfully restore the healthy, Lactobacillus-dominant vaginal environment and prevent complications like preterm birth or increased susceptibility to sexually transmitted infections.

Other names
Bacterial vaginosis biofilmBV biofilmMultispecies vaginal biofilmVaginal microbial biofilm
02

Mechanism of action

Drugs targeting these biofilms typically employ mechanisms such as the chemical disruption of the EPS matrix (e.g., boric acid), enzymatic degradation of biofilm components (e.g., DNase), or the use of broad-spectrum antiseptics like dequalinium chloride that penetrate the biofilm more effectively than traditional antibiotics (Machado et al., 2015; Gottschick et al., 2017). Additionally, some therapies aim to prevent the initial adhesion of Gardnerella vaginalis to the vaginal mucosa, thereby inhibiting the formation of the biofilm scaffold (Cerca et al., 2022).

03

Biological functions

Microbial adhesionAntimicrobial resistanceHost immune evasionPathogen persistenceNiche colonization
04

Disease associations

Bacterial vaginosisPelvic inflammatory diseasePreterm birthSexually transmitted infectionInfertility
05

Safety considerations

High recurrence rates due to incomplete eradicationDisruption of protective Lactobacillus speciesDevelopment of antimicrobial resistanceLocal vaginal irritation or vulvovaginitisPotential for ascending infections if biofilm is disturbed but not eliminated
06

Interacting drugs

Metronidazole

7 more in the full profile.

07

Biomarkers

Nugent scoreAmsel criteriaGardnerella vaginalis loadAtopobium vaginae presenceSialidase activityClue cells

Beyond the preview

Go deeper on Vaginal polymicrobial biofilm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal polymicrobial biofilm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call